Saulye Sherrell

Vice President, U.S. Technical Operations

Saulye Sherrell is responsible for the direction, strategy, planning and delivery of the company’s manufacturing facility and management of the Parsippany site.

Saulye has over 15 years of experience in both commercial and clinical manufacturing working in companies including Bayer Healthcare, Genentech, PCT Hitachi Chemical Advanced Therapeutics, and most recently Miltenyi Biotec where she was the General Manager and Site Head for of the company’s Sunnyvale, California facility.

Saulye holds a Bachelor of Science degree and a Master of Science in molecular genetics from Kazakh National University in Almaty, Kazakhstan.

This site contains material about Ferring Pharmaceuticals Inc. (hereinafter "Ferring") and its various products that may be of interest to Ferring's employees and customers, as well as to members of the health care community and the general public. Please feel free to browse this web site. Your access and use of the information contained herein is subject to the following terms and conditions and all applicable laws. By accessing and browsing this web site, you accept, without limitation or qualification, these terms and conditions and acknowledge that they supersede any other agreement between you and Ferring.

All information on this site is intended for US audiences only.

CERVIDIL, CLENPIQ, ENDOMETRIN, EUFLEXXA, FIRMAGON, MENOPUR, NOCDURNA, NOVAREL, and ZOMACTON are registered trademarks of Ferring B.V. INVOCELL is a registered trademark of INVO BioScience. ORTIKOS is a trademark of Sun Pharma Global FZE.

©2008-2020 Ferring Pharmaceuticals.  US-CORP-2100028